FTC Investigates Epic Systems Over Antitrust Concerns

The US Federal Trade Commission (FTC) has launched an investigation into Epic Systems, a company that holds the medical records of hundreds of millions of Americans. According to sources familiar with the matter, the FTC is looking into whether Epic's practices are anticompetitive.

Epic Systems is a major player in the healthcare technology industry, providing electronic health record systems to healthcare providers that treat over 280 million people in the US. The company's products include the patient web portal MyChart, as well as other electronic health record systems.

Investigation Details

The FTC has sent investigative demands to other companies in the health technology industry, seeking information about how Epic grants or withholds data access. This suggests that the FTC is looking into whether Epic is using its market position to restrict access to patient data, potentially stifling competition.

An Epic spokesperson has denied any wrongdoing, stating that the company is a leader in interoperability and does not engage in anticompetitive behavior. However, others have accused Epic of shutting out rivals by holding data hostage. Texas Attorney General Ken Paxton has sued Epic, alleging that the company is using restrictions and fees to prevent healthcare systems from using competitors' products.

Allegations of Anticompetitive Behavior

Epic has denied these allegations, stating that its products are interoperable with outside systems and that healthcare providers, not Epic, control access to patient records. However, Particle Health, a competitor of Epic's, has also sued the company, accusing it of setting up barriers for potential new clients. Epic has called this lawsuit baseless and has made allegations of its own against Particle Health.

Implications of the Investigation

The FTC's investigation into Epic Systems has significant implications for the healthcare technology industry. If the FTC finds that Epic has engaged in anticompetitive behavior, it could lead to significant changes in the way the company operates. This could potentially open up the market to more competition, which could lead to better services and lower prices for healthcare providers and patients.

The investigation is also a reminder of the importance of ensuring that companies do not use their market position to stifle competition. As the healthcare technology industry continues to evolve, it is crucial that companies prioritize interoperability and patient care, rather than trying to restrict access to data and shut out rivals.